Welcome to our dedicated page for Roma Green Finance, Ltd. SEC filings (Ticker: ROMA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Looking for the story behind Roma Green Finance’s ESG consulting numbers or the latest insider moves? Most visitors start here, searching “ROMA quarterly earnings report 10-Q filing” or “ROMA insider trading Form 4 transactions”. This page gathers every SEC disclosure so you can explore how the firm’s sustainability advice turns into fee revenue, margins, and future pipeline.
Scroll down for real-time updates straight from EDGAR—whether it’s an 8-K on a new advisory mandate, a 10-K detailing segment growth, or a proxy that maps executive compensation to climate targets. Stock Titan’s AI-powered summaries cut through accounting jargon, highlighting where ROMA explains client concentration risk, climate-regulation opportunities, and cash-flow timing. Need the quick take? Our concise overviews answer common searches such as “ROMA annual report 10-K simplified” and “understanding ROMA SEC documents with AI.”
Key resources available:
- 10-Q & 10-K: AI identifies ESG consulting revenue, cost trends, and critical risk factors for easy comparison.
- Form 4: Track ROMA executive stock transactions in real time—perfect for spotting buying or selling patterns.
- 8-K material events explained: From new climate-strategy partnerships to governance changes, see impacts in minutes.
- Proxy statement executive compensation: Understand how pay aligns with sustainability milestones.
Whether you’re parsing “ROMA Form 4 insider transactions real-time” alerts or performing a deep dive into “ROMA earnings report filing analysis,” our platform turns dense disclosures into actionable insights—no extra spreadsheets required.
GSK plc disclosed the latest daily tranche of its on-market share buy-back programme in a Form 6-K for 7 July 2025.
- Shares repurchased: 485,199 ordinary shares (nominal value 31¼ p) via Merrill Lynch International.
- Price range: 1,387.50 p – 1,404.00 p; VWAP: 1,395.87 p.
- Cost of this tranche: approx. £6.8 million.
- Cumulative since programme start (4 Jun 2025): 10,463,692 shares.
- Treasury position: 228,598,075 shares, representing 5.59 % of total voting rights.
- Shares in issue (ex-treasury): 4,086,783,775.
The repurchase is executed under a non-discretionary agreement announced on 4 June 2025 and does not change the previously communicated aggregate buy-back ceiling. The information enables investors to update free-float and voting-rights calculations and signals continued capital returns, albeit in routine daily volumes.